Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer's disease
Subjective cognitive decline (SCD) is regarded as the first clinical manifestation in the
Alzheimer's disease (AD) continuum. Investigating populations with SCD is important for …
Alzheimer's disease (AD) continuum. Investigating populations with SCD is important for …
Alzheimer's disease including focal presentations
Alzheimer's disease (AD) is the commonest neurodegenerative disease and the most
frequent cause of dementia. It affects 30 million people worldwide. Current research criteria …
frequent cause of dementia. It affects 30 million people worldwide. Current research criteria …
The impact of amyloid‐beta and tau on prospective cognitive decline in older individuals
Objectives Amyloid‐beta (Aβ) and tau pathologies are commonly observed among clinically
normal older individuals at postmortem and can now be detected with in vivo neuroimaging …
normal older individuals at postmortem and can now be detected with in vivo neuroimaging …
Pilot study of repeated blood-brain barrier disruption in patients with mild Alzheimer's disease with an implantable ultrasound device
Background Temporary disruption of the blood-brain barrier (BBB) using pulsed ultrasound
leads to the clearance of both amyloid and tau from the brain, increased neurogenesis, and …
leads to the clearance of both amyloid and tau from the brain, increased neurogenesis, and …
Diagnosis of Alzheimer's disease and behavioural variant frontotemporal dementia with machine learning‐aided neuropsychological assessment using feature …
Background Neuropsychological assessment is considered a valid tool in the diagnosis of
neurodegenerative disorders. However, there is an important overlap in cognitive profiles …
neurodegenerative disorders. However, there is an important overlap in cognitive profiles …
“Brain Fog” by COVID-19 or Alzheimer's disease? A case report
Cognitive symptoms after COVID-19 have been increasingly recognized several months
after the acute infection and have been designated as “brain fog.” We report a patient with …
after the acute infection and have been designated as “brain fog.” We report a patient with …
Association between increased levels of amyloid-β oligomers in plasma and episodic memory loss in Alzheimer's disease
Objective The objectives of this study were to investigate whether the plasma levels of
oligomeric amyloid-β (OAβ) were affected in Alzheimer's disease (AD) and to examine the …
oligomeric amyloid-β (OAβ) were affected in Alzheimer's disease (AD) and to examine the …
Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe
Introduction Harmonized neuropsychological assessment for neurocognitive disorders, an
international priority for valid and reliable diagnostic procedures, has been achieved only in …
international priority for valid and reliable diagnostic procedures, has been achieved only in …
Validation of neuropsychological tests for the China health and retirement longitudinal study harmonized cognitive assessment protocol
Objective: To compare and validate neurocognitive tests in the Harmonized Cognitive
Assessment Protocol (HCAP) for the China Health and Retirement Longitudinal Study …
Assessment Protocol (HCAP) for the China Health and Retirement Longitudinal Study …
Refining understanding of working memory buffers through the construct of binding: Evidence from a single case informs theory and clinical practise
Binding operations carried out in working memory enable the integration of information from
different sources during online performance. While available evidence suggests that …
different sources during online performance. While available evidence suggests that …